health
Prolactin Level Reduction
Prolactin level reduction refers to lowering the amount of prolactin in the body. It is an outcome, not a diagnosis or a symptom by itself, and may be considered in contexts such as hyperprolactinemia and PMS.
A focused look at prolactin level reduction and its place among health effects.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What may help
None of these options has good evidence yet. Best evidence first.
4 options:1 not enough evidence1 personal stories only2 no benefit found
High-Intensity Interval Training (HIIT)practiceNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a randomized controlled trial.
A 2025 trial of 65 people reported decreased prolactin levels after HIIT in the DysmenEx and DysmenExPro groups.
Open the High-Intensity Interval Training (HIIT) pageFastingpracticeOnly personal stories
DancepracticeNo benefit found
Studies looked for a benefit and did not find one.
The one study found no benefit. Strongest study: a randomized controlled trial.
An RCT involving 58 people with Schizophrenia found no significant interaction effects on prolactin, so this study did not support a prolactin-lowering effect.
Open the Dance pageFinnish SaunapracticeNo benefit found
Studies looked for a benefit and did not find one.
The one study found no benefit. Strongest study: a non-randomized trial.
The evidence summary does not support prolactin reduction as an established effect; a 2021 quasi-experimental study of 30 people recorded PRL decreasing from 14.50 to 13.71 ng/ml.
Open the Finnish Sauna page
The expert view shows every study, dose protocol and source.
What may help
Linked to improving it4 listedStart here
The best we have, but the evidence is still weak
- →PracticesHigh-Intensity Interval Training (HIIT)CertaintyLowSourceClinical1 other source
A 2025 trial of 65 people reported decreased prolactin levels after HIIT in the DysmenEx and DysmenExPro groups.
Who was studied
- People with a condition
Open High-Intensity Interval Training (HIIT)Study result
significant decreases in ... prolactin levels ... in the DysmenEx and DysmenExPro groups as a result of HIIT intervention
- →PracticesFastingCertaintyLowSourceAnecdotal1 other source
This effect was mentioned in 2 of 425 Reddit reports discussing it.
Very low probability(2)
- →PracticesDanceCertaintyVery lowSourceClinical1 other source
An RCT involving 58 people with Schizophrenia found no significant interaction effects on prolactin (F=0.60, p=0.44), so this study did not support a prolactin-lowering effect.
Open DanceWho was studied
- People with a condition
- Schizophrenia
- →PracticesFinnish SaunaCertaintyVery lowSourceClinical1 other source
The evidence summary does not support prolactin reduction as an established effect; a 2021 quasi-experimental study of 30 people recorded PRL decreasing from 14.50 to 13.71 ng/ml.
Open Finnish SaunaWho was studied
- Healthy people
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Prolactin level reduction refers to lowering the amount of prolactin in the body. It is an outcome, not a diagnosis or a symptom by itself, and may be considered in contexts such as hyperprolactinemia and PMS. Vitamin B6 (Pyridoxine) and Berberine are examples of interventions studied in relation to this effect.
How interventions help
Vitamin B6 (Pyridoxine) is described as lowering prolactin through modulation of dopamine pathways, with findings discussed in the contexts of hyperprolactinemia and PMS. The typical course is 100-200 mg/day for 2-3 months. Daily use is not marked as required, so the information does not establish that it must be taken every day for this outcome.
Berberine was evaluated over 3 months at 500 mg tid alongside another intervention. In that comparison, the combination produced a greater reduction in prolactin than the other intervention alone. This represents a combined-treatment finding rather than evidence that berberine’s effect is independent of other treatment.
These approaches differ in both their proposed basis and how they were studied: Vitamin B6 is linked to dopamine pathway modulation, whereas the berberine finding concerns use alongside another intervention. The described courses run for months, and no conclusion about whether prolactin changes persist after stopping is provided. The findings are not identified as human evidence, and the health status of the studied populations is not specified.
Choosing guidance
Vitamin B6 (Pyridoxine) and Berberine are not interchangeable options in how they have been examined. Vitamin B6 is associated with prolactin-lowering effects through dopamine pathway modulation, with a typical dose of 100-200 mg/day over 2-3 months. Berberine is listed at 500 mg tid for 3 months, so its typical use involves repeated dosing across the day and a similar overall treatment period.
Neither option has human evidence identified here, and the health status of the studied populations is not specified. This limits how confidently either can be matched to a particular person or used to draw conclusions about human prolactin levels. The information also does not establish how quickly a change might appear; the stated durations should not be read as an onset time.
For Berberine, the reported finding concerns use alongside MET rather than Berberine alone, which makes the result less directly applicable when considering it as a standalone option. Conflicting evidence is not identified for Berberine, but the limited evidence base still leaves uncertainty about its practical relevance. These options may therefore be of interest for reference or further discussion, but the information does not establish that either is suitable for a specific individual.